for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Getinge AB

GETIb.ST

Latest Trade

197.70SEK

Change

2.20(+1.13%)

Volume

948,663

Today's Range

196.90

 - 

202.30

52 Week Range

129.05

 - 

217.20

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
195.50
Open
196.90
Volume
948,663
3M AVG Volume
21.51
Today's High
202.30
Today's Low
196.90
52 Week High
217.20
52 Week Low
129.05
Shares Out (MIL)
272.37
Market Cap (MIL)
49,686.79
Forward P/E
18.53
Dividend (Yield %)
0.77

Next Event

Q3 2020 Getinge AB Earnings Release

Latest Developments

More

Getinge Partners Up With Universeum

Getinge: Flow-E And Flow-C Get 510(K)-Approval For The American Market

CEO says 2020 CAPEX will be roughly in line with recent years'

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Getinge AB

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The Company's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands.

Industry

Medical Equipment & Supplies

Contact Info

Ekebergsvagen 26,

P.O. Box 69

305 75

Sweden

+46.3.5155500

http://www.getingegroup.com/

Executive Leadership

Johan Malmquist

Chairman of the Board

Mattias Perjos

President, Chief Executive Officer, Director

Carl Bennet

Vice Chairman of the Board

Lars Sandstrom

Chief Financial Officer

Magnus Lundback

Executive Vice President - Human Resources & Sustainability

Key Stats

2.15 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, SEK)

2017

22.5K

2018

24.2K

2019

26.6K

2020(E)

30.2K
EPS (SEK)

2017

8.520

2018

5.910

2019

7.020

2020(E)

11.063
Price To Earnings (TTM)
28.35
Price To Sales (TTM)
1.79
Price To Book (MRQ)
2.56
Price To Cash Flow (TTM)
11.62
Total Debt To Equity (MRQ)
63.88
LT Debt To Equity (MRQ)
63.88
Return on Investment (TTM)
4.78
Return on Equity (TTM)
4.03

Latest News

Latest News

BRIEF-Getinge Q1 Adjusted EBITA Up At SEK 661 Mln

* GETINGE INTERIM REPORT FOR JANUARY-MARCH 2020: INTENSE EFFORTS TO HELP HOSPITALS IN THE COVID-19 PANDEMIC

BRIEF-Getinge Issues COVID-19 Commercial Paper Of SEK 1 Bln

* DUE DATE OCT 21, 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Getinge Q1 Adjusted EBITA Up At About SEK 660 Mln

* TO POST HIGHER THAN EXPECTED ORDER GROWTH AND EARNINGS FOR Q1 2020 AND WITHDRAWS OUTLOOK FOR 2020

BRIEF-Getinge To Further Increase Production Capacity Of Ventilators In 2020

* GETINGE TO FURTHER INCREASE PRODUCTION CAPACITY OF VENTILATORS IN 2020

BRIEF-Getinge Enters Partnership With WaterAid

* GETINGE AND WATERAID PARTNER UP TO STRENGTHEN ACCESS TO CLEAN WATER, SANITATION AND HYGIENE AT HEALTH CARE FACILITIES AROUND THE WORLD

BRIEF-Getinge Increases Production Capacity Of Ventilators With 60% To Support The Needs Of Global Intensive Care Units

* GETINGE INCREASES PRODUCTION CAPACITY OF VENTILATORS WITH 60% TO SUPPORT THE NEEDS OF GLOBAL INTENSIVE CARE UNITS

BRIEF-Getinge Acquires Applikon Biotech

* UNDER THE TERMS, GETINGE WILL ACQUIRE ALL OUTSTANDING SHARES IN APPLIKON BIOTECHNOLOGY AND WILL PAY APPROXIMATELY SEK 840 MILLION IN CASH ON CLOSING FOR 100 % OF THE SHARES

BRIEF-Getinge Q3 Adjusted EBITA Up At SEK 677 Million

* Q3 NET SALES SEK 6,236 MILLION (REFINITIV POLL: SEK 6,074 MILLION)

UPDATE 1-Sweden's Getinge order book beat sends shares higher

Swedish medical technology group Getinge reported stronger than expected orders thanks to a robust performance in capital goods and in emerging markets, sending its stock up more than 10 percent on Tuesday.

Sweden's Getinge says costs could rise as Q2 earnings lag

Swedish medical technology group Getinge said that it might see higher operating expenses in future quarters, after second-quarter core earnings missed expectations as higher demand for certain products and in some markets inflated costs and hit margins.

Getinge to step up cost cuts after deeper-than-expected Q1 loss

Swedish medical technology group Getinge said on Thursday it would step up cost cuts after it reported a bigger than expected operating loss for the first quarter, sending its shares down nearly 5 percent.

BRIEF-Getinge Q1 operating result lags forecast

* Q1 OPERATING PROFIT (EBIT) AMOUNTED TO SEK -161 M (302), CURRENCY EFFECTS HAD A NEGATIVE IMPACT OF SEK -115 M ON EBIT

Getinge makes another provision for Brazil fraud probe

Swedish medical technology group Getinge said on Wednesday it would book a 350 million crown ($42.6 million) provision in the first quarter related mainly to a fraud probe in Brazil.

Getinge core profit lags forecast, sees slight growth in 2018

Swedish medical technology group Getinge on Monday reported a fourth-quarter core profit far below market forecasts and said it expected slight growth in organic sales this year.

BRIEF-Getinge Q4 core profit far below forecast​

* Q4 EBITA 1** AMOUNTED TO SEK 1,111 M (1,689) WITH AN EBITA 1 MARGIN OF 15.1% (22.7)

UPDATE 1-Getinge sets new financial targets ahead of Arjo listing

Swedish medical technology firm Getinge on Friday announced new financial targets following the proposed distribution and separate listing of its patient & post-acute care business, now called Arjo.

BRIEF-Getinge sets new financial targets after distribution of Arjo

* Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo)

REFILE-UPDATE 2-Getinge hopes to spin off PPAC division this year after Q3 profit dives

Medical technology firm Getinge reported on Wednesday quarterly core profits below expectations, sending its shares down, and said it now hoped to spin off and list its smallest division by year-end.

BRIEF-Getinge Q3 core profit lags expectations, targets PPAC listing by year-end ​

* Q3 order intake increased by 2.2% to sek 7,334 m (7,176). Order intake increased organically by 4.7%.

BRIEF-Getinge's rights issue fully subscribed

* The preliminary result of Getinge rights issue shows that over 33.7 million shares, corresponding to approximately 99.2 percent of the shares in the offer, were subscribed for with subscription rights

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up